Skip to main content
Premium Trial:

Request an Annual Quote

Abbott Labs, Compugen Work Together In mRNA Database Project

NEW YORK, Jan. 15-Abbott Laboratories and Compugen will work together to create a comprehensive human mRNA database, the two companies said today.


In this deal, Abbott has secured a license to LEADS, Compugen's computational biology platform. Working together, the two companies will use the platform to model genes, mRNA transcripts, and other genomic information. Abbott will use this data and public data from Compugen's Gencarta system to select new drug targets.


Financial details of the deal were not revealed.


For further information, see the press release.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.